Cargando…

Rotavirus Vaccines: a story of success with challenges ahead

Approximately 40 years have passed since the discovery of the rotavirus and 10 years since the introduction and progressive dissemination of rotavirus vaccines worldwide. Currently, 92 countries have introduced rotavirus vaccines into national or subnational programs with evident impact in disease r...

Descripción completa

Detalles Bibliográficos
Autor principal: O’Ryan, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580433/
https://www.ncbi.nlm.nih.gov/pubmed/28928954
http://dx.doi.org/10.12688/f1000research.11912.1
_version_ 1783260899028500480
author O’Ryan, Miguel
author_facet O’Ryan, Miguel
author_sort O’Ryan, Miguel
collection PubMed
description Approximately 40 years have passed since the discovery of the rotavirus and 10 years since the introduction and progressive dissemination of rotavirus vaccines worldwide. Currently, 92 countries have introduced rotavirus vaccines into national or subnational programs with evident impact in disease reduction. Two vaccines have been widely used, and four additional vaccines have been licensed and are being used in defined regions. In this context, one main issue that remains unsolved is the lower vaccine efficacy/effectiveness in low-income countries. An additional partially answered issue relates to rotavirus strain circulation in vaccinated populations. These issues are discussed in this review. The most imperative challenge ahead is to fulfill the WHO’s recommendation to introduce rotavirus vaccines in all countries.
format Online
Article
Text
id pubmed-5580433
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-55804332017-09-18 Rotavirus Vaccines: a story of success with challenges ahead O’Ryan, Miguel F1000Res Review Approximately 40 years have passed since the discovery of the rotavirus and 10 years since the introduction and progressive dissemination of rotavirus vaccines worldwide. Currently, 92 countries have introduced rotavirus vaccines into national or subnational programs with evident impact in disease reduction. Two vaccines have been widely used, and four additional vaccines have been licensed and are being used in defined regions. In this context, one main issue that remains unsolved is the lower vaccine efficacy/effectiveness in low-income countries. An additional partially answered issue relates to rotavirus strain circulation in vaccinated populations. These issues are discussed in this review. The most imperative challenge ahead is to fulfill the WHO’s recommendation to introduce rotavirus vaccines in all countries. F1000Research 2017-08-18 /pmc/articles/PMC5580433/ /pubmed/28928954 http://dx.doi.org/10.12688/f1000research.11912.1 Text en Copyright: © 2017 O’Ryan M http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
O’Ryan, Miguel
Rotavirus Vaccines: a story of success with challenges ahead
title Rotavirus Vaccines: a story of success with challenges ahead
title_full Rotavirus Vaccines: a story of success with challenges ahead
title_fullStr Rotavirus Vaccines: a story of success with challenges ahead
title_full_unstemmed Rotavirus Vaccines: a story of success with challenges ahead
title_short Rotavirus Vaccines: a story of success with challenges ahead
title_sort rotavirus vaccines: a story of success with challenges ahead
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580433/
https://www.ncbi.nlm.nih.gov/pubmed/28928954
http://dx.doi.org/10.12688/f1000research.11912.1
work_keys_str_mv AT oryanmiguel rotavirusvaccinesastoryofsuccesswithchallengesahead